Cargando…
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma
BACKGROUND: Recent findings have shown that up to 60% of pheochromocytomas (PCCs) and paragangliomas (PGLs) are caused by germline or somatic mutations in one of the 11 hitherto known susceptibility genes: SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, HIF2A (EPAS1), RET, NF1, TMEM127 and MAX. This list of ge...
Autores principales: | Crona, Joakim, Verdugo, Alberto Delgado, Granberg, Dan, Welin, Staffan, Stålberg, Peter, Hellman, Per, Björklund, Peyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682230/ https://www.ncbi.nlm.nih.gov/pubmed/23781326 http://dx.doi.org/10.1530/EC-13-0009 |
Ejemplares similares
-
Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours
por: Crona, Joakim, et al.
Publicado: (2014) -
Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma
por: Crona, Joakim, et al.
Publicado: (2015) -
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018) -
Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations
por: Backman, Samuel, et al.
Publicado: (2017) -
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with (177)Lu-DOTATATE
por: Vyakaranam, Achyut Ram, et al.
Publicado: (2019)